OnKure Therapeutics, Inc. OKUR Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s investing cash flow?
- OnKure Therapeutics, Inc. (OKUR) reported investing cash flow of -$5K in Q1 2026.
- How has OnKure Therapeutics, Inc.'s investing cash flow changed year-over-year?
- OnKure Therapeutics, Inc.'s investing cash flow increased by 72.2% year-over-year, from -$18K to -$5K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s investing cash flow?
- Over 2 years (2022 to 2025), OnKure Therapeutics, Inc.'s investing cash flow has grown at a -97.2% compound annual growth rate (CAGR), from -$57.84M to -$46K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.